
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.305 | -13.8636363636 | 2.2 | 2.24 | 1.7501 | 41080 | 1.91867699 | CS |
4 | -0.735 | -27.9467680608 | 2.63 | 2.89 | 1.7501 | 26741 | 2.24676146 | CS |
12 | -1.115 | -37.0431893688 | 3.01 | 3.61 | 1.7501 | 31541 | 2.79756585 | CS |
26 | -1.545 | -44.9127906977 | 3.44 | 23.8 | 1.7501 | 1347530 | 12.0548897 | CS |
52 | -2.665 | -58.4429824561 | 4.56 | 23.8 | 1.7501 | 809287 | 10.69305471 | CS |
156 | -253.705 | -99.2586071987 | 255.6 | 330.858 | 1.7501 | 366372 | 23.17437719 | CS |
260 | -854.905 | -99.7788281979 | 856.8 | 1126.782 | 1.7501 | 291268 | 176.52506722 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관